These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 19528429)

  • 1. Optimizing clinical use of azathioprine with newer pharmacogenetic data.
    Wolverton SE
    Arch Dermatol; 2009 Jun; 145(6):707-10. PubMed ID: 19528429
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and tolerability at 3 and 6 months following use of azathioprine for recalcitrant atopic dermatitis in children and young adults.
    Hon KL; Ching GK; Leung TF; Chow CM; Lee KK; Ng PC
    J Dermatolog Treat; 2009; 20(3):141-5. PubMed ID: 18951236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further experience of using azathioprine in the treatment of severe atopic dermatitis.
    Hughes R; Collins P; Rogers S
    Clin Exp Dermatol; 2008 Nov; 33(6):710-1. PubMed ID: 18681884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azathioprine hypersensitivity: report of two cases and review of the literature.
    Sinico RA; Sabadini E; Borlandelli S; Cosci P; Di Toma L; Imbasciati E
    J Nephrol; 2003; 16(2):272-6. PubMed ID: 12768076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cutaneous and systemic manifestations of azathioprine hypersensitivity syndrome.
    Bidinger JJ; Sky K; Battafarano DF; Henning JS
    J Am Acad Dermatol; 2011 Jul; 65(1):184-91. PubMed ID: 21496951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Life threatening myelotoxicity secondary to azathioprine in a patient with atopic eczema and normal thiopurine methyltransferase activity.
    Wee JS; Marinaki A; Smith CH
    BMJ; 2011 Mar; 342():d1417. PubMed ID: 21441287
    [No Abstract]   [Full Text] [Related]  

  • 7. Azathioprine in dermatology: a survey of current practice in the U.K.
    Tan BB; Lear JT; Gawkrodger DJ; English JS
    Br J Dermatol; 1997 Mar; 136(3):351-5. PubMed ID: 9115914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines for prescribing azathioprine in dermatology.
    Anstey AV; Wakelin S; Reynolds NJ;
    Br J Dermatol; 2004 Dec; 151(6):1123-32. PubMed ID: 15606506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinically integrated care. Shared care/blame arrangements.
    Thiryayi WA
    BMJ; 2011 Apr; 342():d2412. PubMed ID: 21502272
    [No Abstract]   [Full Text] [Related]  

  • 10. Retrospective review of the use of azathioprine in severe atopic dermatitis.
    Lear JT; English JS; Jones P; Smith AG
    J Am Acad Dermatol; 1996 Oct; 35(4):642-3. PubMed ID: 8859304
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of canine atopic dermatitis with azathioprine: a pilot study.
    Favrot C; Reichmuth P; Olivry T
    Vet Rec; 2007 Apr; 160(15):520-1. PubMed ID: 17435099
    [No Abstract]   [Full Text] [Related]  

  • 12. The adverse effect profile of oral azathioprine in pediatric atopic dermatitis, and recommendations for monitoring.
    Fuggle NR; Bragoli W; Mahto A; Glover M; Martinez AE; Kinsler VA
    J Am Acad Dermatol; 2015 Jan; 72(1):108-14. PubMed ID: 25440430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atopic dermatitis: systemic immunosuppressive therapy.
    Akhavan A; Rudikoff D
    Semin Cutan Med Surg; 2008 Jun; 27(2):151-5. PubMed ID: 18620137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute generalized exanthematous pustulosis associated with azathioprine hypersensitivity.
    Elston GE; Johnston GA; Mortimer NJ; Harman KE
    Clin Exp Dermatol; 2007 Jan; 32(1):52-3. PubMed ID: 17004986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Should immunosuppressors be used for the treatment of atopic dermatitis?].
    De Prost Y
    Ann Dermatol Venereol; 2000; 127(8-9):697-700. PubMed ID: 11011157
    [No Abstract]   [Full Text] [Related]  

  • 16. Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial.
    Berth-Jones J; Takwale A; Tan E; Barclay G; Agarwal S; Ahmed I; Hotchkiss K; Graham-Brown RA
    Br J Dermatol; 2002 Aug; 147(2):324-30. PubMed ID: 12174106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allopurinol Co-prescription Improves the Outcome of Azathioprine Treatment in Chronic Eczema.
    Garritsen FM; van der Schaft J; de Graaf M; Hijnen DJ; Bruijnzeel-Koomen CAF; van den Broek MPH; De Bruin-Weller MS
    Acta Derm Venereol; 2018 Mar; 98(3):373-375. PubMed ID: 29136268
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical improvement and significant reduction of total serum IgE in patients suffering from severe atopic dermatitis treated with oral azathioprine.
    Kuanprasert N; Herbert O; Barnetson RS
    Australas J Dermatol; 2002 May; 43(2):125-7. PubMed ID: 11982569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nodular regenerative hyperplasia and thiopurines: the case for level-dependent toxicity.
    de Boer NK; Mulder CJ; van Bodegraven AA
    Liver Transpl; 2005 Oct; 11(10):1300-1. PubMed ID: 16184561
    [No Abstract]   [Full Text] [Related]  

  • 20. Review article: Progress of treatment in ANCA-associated vasculitis.
    Jayne D
    Nephrology (Carlton); 2009 Feb; 14(1):42-8. PubMed ID: 19335843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.